Genetic risk markers and misrepresentation – The Medium

The Medium recently had the chance to sit down with Dr. EstebanParra, a molecular anthropologist and anthropology professor at the Universityof Toronto Mississauga (UTM).

Parra has hada long and far-reaching journey in science which began in one of the oldestuniversities in Spain, the University of Santiago de Compostela. He began hisstudies in biology and like many students everywhere [he] discovered what [hewas] really passionate about while completing his undergraduate degree.

For Parra, thediscovered passion was anthropology and genetics. After completing his Ph.D.degree, he completed a postdoctoral fellowship at a molecular anthropology labin Spain. He was also a post-doctoral fellow in Rome, Italy, and Pittsburgh,USA, before joining UTM in 2002. Parra advises those interested in graduatestudies to be willing to follow the opportunities that arise. For him, it hasbeen incredibly exciting to see how the UTM campus has changed and grown inthe past seventeen years. We have been attracting incredible new faculty, notonly to anthropology but to many other programs, which has been nice to see,he says.

Parra hascontinued his research at UTM. One of the focuses of his research is toidentify some of the genetic risk markers of traits and diseases such asobesity, type 2 diabetes, cardiovascular diseases, and cancer. This is doneusing a genome wide association study to identify variants that are associatedwith these traits. Parra uses a consortiaa large group of samplesto haveaccess to as much data as possible. The more samples there are, the higherchance there is of finding a common link between the genetics of an individualand the ailments they suffer from.

Parra doesmention that genetics are often not the only cause. For diseases such as cysticfibrosis, ones genes are the primary factor in causing the condition. Thesediseases are termed Mendelian disorders. However, for complex conditions likeobesity and diabetes, ones environment and lifestyle play a huge role.Modifications in your lifestyle, your diet, and physical activity, are thebest way to combat conditions such as obesity and diabetes, said Parra.

An excitingdevelopment Parra is looking forward to is the advancement of precisionmedicine. Precision medicineor personalized medicine as it is sometimesreferred tois when an individuals genetic profile can be used to develop atailor-made treatment program for the individual. Precision medicine is a newfield because it has only recently been made possible by technologicaladvancements, which have also lowered the cost of genetic studies dramatically,and, in turn, opened many doors in the field of genetics.

Parraemphasizes the importance of collecting as much data as possible. The best wayto approach this is to collaborate with other scientists [] there are somestudies that are done with many participating research groups, and they havebeen able to use samples of up to a million individuals.

One of theadvantages of collecting a large number of samples is balanced representationof diverse ethnic groups, which for Parra is very important. He explains thatgenetic studies in the past have primarily been conducted in European countrieswhich is problematic for the future of precision medicine. When you primarilywork in just one population group, it may not be as helpful for the rest of theworld, he says.

In fact, foralmost all non-European groups, underrepresentation is a significant issuewhich is only improving slowly. Underrepresentation can be attributed to avariety of factors such as biasness and the location of the research groups whogenerally choose to perform their research in their own areas. Parra encouragesthose conducting research to overcome these factors since it is absolutelycritical to do more studies and represent these groups.

Parra hascontributed in his own right to the growth of the sample pool. One of thestudies he participated in was part of a large collaboration with researchersfrom around the world. Together, the researchers collected samples from overeighteen thousand individuals of various ethnicities. Since very few studieshad been previously conducted on non-European populations, they focused onlooking for genetic markers of obesity in children. Ultimately, they discovereda new locusa fixed position on a chromosome where a genetic marker is located.The locus they had discovered had not been found in significant numbers inpurely European groups, but appeared consistently in the diverse sample pool,exemplifying the need for more diverse sources.

Despite theshortcomings, Parra is hopeful about the future of the field and its growth. Heencourages greater awareness of the disparity of samples and urges efforts torectify the misrepresentation. He is immensely passionate about anthropologyand genetics and finishes off by stating, DNA is an open bookyou just need toknow how to read it.

Read more:
Genetic risk markers and misrepresentation - The Medium

Chemistry and biochemistry professor recognized for strength of teaching, research – UMSL Daily

The National Society of Leadership and Success recognized Distinguished Professor of Chemistry and Biochemistry George Gokel for the quality of his teaching at the end of last year. (Photo by August Jennewein)

When George Gokel opened the email informing him that hed won a teaching award from the National Society of Leadership and Success, the University of MissouriSt. Louis professor was grateful but surprised.

I didnt know the organization, Gokel said. I sent a message to the chair, asking him if he knew the organization. You can imagine how stunned I was when I saw a couple of hundred people assembled there when we got to the actual meeting.

Gokel, a distinguished professor of chemistry and biochemistry and former director of the Center for NanoScience, has accomplished a long list of achievements, which includes 16 patents and becoming a Fellow of the National Academy of Inventors. Hes also been recognized with the American Chemical Society Midwest Award, the James B. Eads Award of the Academy of Science, the UMSL Chancellors Award for Excellence in Research and Creativity and more.

A faculty member as distinguished as Gokel could justifiably focus on research and not on teaching, but he cares deeply about giving his students a quality education. Thats what makes this award especially poignant for Gokel.

It means a great deal to me because I put a great deal of effort into teaching, he said. People are sometimes surprised that I teach undergraduates, but I think undergraduates deserve to have experienced scientists teaching them. Theres a lot of new language in organic chemistry. It can be befuddling, but it doesnt need to be. Its actually a very logical discipline. But most students come in being scared of the course, so you need to start off simply and explain that theres nothing mystical or unreasonable.

Gokel rotates between teaching Organic Chemistry, Advanced Physical Organic Chemistry and a graduate seminar.

Gokel values presenting his students with material in a manner that is contemporaneous and engaging. For Gokel, that means no teaching from notes but instead focusing on key topics during each lesson. He believes in helping students learn unfamiliar terms and concepts by comparing them to familiar ones.

Hearing from students whove found his courses valuable is the best reward in Gokels mind.

I know that Ive had a positive effect on peoples lives, he said. I get a lot of satisfaction out of that. I think part of the reason we should be in a university is we should be teaching. My research has been very important to me, and Ive done OK. But teaching is important, and I like it.

Gokel is known at UMSL and beyond for his work in synthetic organic chemistry. In November, the United States Patent Office once again recognized the value of Gokels research by issuing his most-recent patent, Molecules that Inhibit Efflux Pumps in Multi-drug Resistant Bacteria and Uses Thereof. Gokels group includes Mohit Patel, research associate in chemistry; Saeedeh Negin, post-doctoral fellow in chemistry; and Michael R.Gokel, an electrical engineer who holds a courtesy appointment at UMSL and is Gokels son.

They started their research with the goal of making an artificial ion channel. Thats a protein that helps pass things, such as nutrients or waste, through a cell membrane. When they accomplished that goal, the group began thinking about how that invention might be useful.

The current patent application uses that artificial channel to help antibiotics get into bacterial cells, which increases the medicines potency. Gokel believes their invention could help combat antibiotic resistance, a growing problem identified by the Centers for Disease Control and Prevention.

It also has a property we did not anticipate of blocking the proteins that would ordinarily push antibiotics out of a cell, he said. More gets in, less antibiotic gets pushed out, so you have a more potent antimicrobial, and were trying to develop that. We have some that have very high activity against several organisms, like pneumonia and tuberculosis. We know that our compounds are quite active against a number of bacteria that are resistant to drugs like Vancomycin, which is a drug of last resort.

Gokels group formed a startup company, Upaya Pharmaceuticals, and has done tests in mice for toxicity and bioavailability, and it is working on developing a way for the molecule to be taken orally in conjunction with antibiotics. By the time the drug is ready for clinical trials, Gokel hopes to sell the company and has already begun to see interest on that front.

Until then, hell be focusing on investigating molecule analogues and other testing with a contract research organization. This work has been supported in part by University of Missouri System FastTrack Funding Awards.

Were still interested in all of the peripheral questions, like how do these compounds actually work? Gokel said. How do they enter membranes? How do they foster ion transport and regulation? But those are the academic questions that we need to answer to better understand the biological activity because the truth is there are lots of interesting materials. There are lots of interesting compounds, but many of them dont have any particular purpose. And these compounds could potentially be lifesaving.

Short URL: https://blogs.umsl.edu/news/?p=83644

See original here:
Chemistry and biochemistry professor recognized for strength of teaching, research - UMSL Daily

Malang’s new songs & # 039; Hamarah & # 039; But get ready to dancing, may be circulated about this time – Sahiwal Tv

new Delhi. After wooing fans with all the groovy lyrics of Mohit Suri's film 'Malang', the producer is currently prepared to win the minds associated with the market with all the most recent track 'Humraah'.

'Humraah' tune of 'Malang' may be circulated the next day 'Hamarah' into the sound of Sachet Tandon is created by Kunal Verma which is circulated the next day and remember the motif associated with the movie, it is an exciting and colorful vibe tune.

->In 'Humrah', people are certain to get a deeper glance at the sizzling biochemistry between Aditya Roy Kapoor and Disha Patani.

Aditya and Disha may be seen performing adventure recreations Aditya and Disha may be seen playing plenty of adventure recreations like sky scuba diving, sub wing, liquid kitesurfing, driving quad bicycles etc. in this tune. While the present launch subject tabs on 'Malang' is showing become a chartbuster hit, the movie's debut tune 'Chala Ghar Chalen' is a soulful tune which has created an unique invest the minds associated with the market.

The film 'Malang' is likely to be circulated about this time 'Malang' is perhaps all set to discharge on 7 February 2020, which was shot in Mauritius, Goa and elements of Mumbai. The exact same, the secret and biochemistry noticed in the truck has actually certainly made it probably the most awaited truck associated with the period.

Malang is directed by Mohit Suri and created by Bhushan Kumar, Krishna Kumar of T-Series, Luv Ranjan, Ankur Garg of Love Films and J Shevakramani of Northern Lights Entertainment.

Read more:
Malang's new songs & # 039; Hamarah & # 039; But get ready to dancing, may be circulated about this time - Sahiwal Tv

Study reveals new mechanism involved in the pathogenesis of IBD – News-Medical.net

Inflammatory bowel disease (IBD) is a category of refractory inflammatory disease, of which ulcerative colitis (UC) and Crohn's disease (CD) are the main types.

Current studies suggest that IBD is a complex autoinflammatory disease determined by genetic and environmental factors, and is the major cause of gastrointestinal cancer. Because of its complex and refractory character, researchers have focused on determining the detailed pathogenesis of IBD and finding an effective therapy for it.

In a study published online in PNAS on Jan. 20, Prof. SUN Bing's team from the Center for Excellence in Molecular and Cellular Science, Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences, in collaboration with Prof. LIU Jie from Huashan Hospital, Fudan University, revealed a new mechanism involved in the pathogenesis of IBD and suggested therapeutic targets for clinical trial.

Among the identified IBD-susceptibility genes (NOD2, IL-23, etc.), extracellular matrix protein-1 (ECM1) gene was found to be strongly related to UC in 2008. Since 2011, several studies from SUN's lab have reported the disease-related functions of ECM1 in Th2, Th17 and Tfh cells. However, no available evidence suggested that ECM1 plays a direct role in IBD.

In this study, the researchers analyzed tissue samples from patients with ulcerative colitis and a DSS-induced IBD mice model.

They found that ECM1 was highly expressed in macrophages, particularly tissue-infiltrated macrophages under inflammatory conditions, and ECM1 expression was significantly induced during IBD progression. The macrophage-specific knockout of ECM1 resulted in increased arginase 1 (ARG1) expression and impaired polarization into the M1 macrophage phenotype after lipopolysaccharide (LPS) treatment.

Further study showed that ECM1 protein could regulate M1 macrophage polarization through the GM-CSF/STAT5 signaling pathway. Pathological changes in mice with dextran sodium sulfate-induced IBD were alleviated by the specific knockout of the ECM1 gene in macrophages.

These results reveal a role for the IBD-susceptibility gene ECM1 in colitis and the possible existence of a GM-CSF/STAT5 regulatory axis in macrophages, indicating that the attenuation of ECM1 function in macrophages is a potential strategy for IBD therapy.

Read more:
Study reveals new mechanism involved in the pathogenesis of IBD - News-Medical.net

The Business Strategies Accepted By Leading Players In The Biochemistry Analyzers Market | (List: Abbott Laboratories,Danaher Corporation and more) -…

The newest research report andinnovative strategies on Biochemistry Analyzers Marketexamined by Marketresearch.biz encloses a comprehensive analysis of the market and was conducted across a variety of industries in various regions to produce more than 100+ page reports. Biochemistry Analyzers concludes with precise and authentic market estimations considering all the parameters and market dynamics. Segmentation of the market is studied specifically to give profound knowledge for supplementary market investments.

Biochemistry Analyzers study is a perfect blend of qualitative and quantifiable information highlighting key market developments, industry, absolute opportunity assessment and competitors challenges in gap analysis and may be trending in the Biochemistry Analyzers market. The strategies followed by leading Biochemistry Analyzers market players which can reflect growth during the forecast period 2020-2029 is analyzed during this report. The past market development, opportunities, and market risks are covered during this study. the elemental Biochemistry Analyzers Market overview, development scope, market dynamics, growth challenges, and influencing factors are briefed.

The Renowned Players-Abbott Laboratories, Danaher Corporation, Hoffman-La Roche Ltd, Meril, Siemens AG, Hologic Inc, Thermo Fisher Scientific Inc, Randox Laboratories Ltd, Beckman Coulter Inc, Horiba Medical

To Comprehend The Complete Report Through TOC, Figures, and Tables, Get Free Sample Copy (Download PDF) @https://marketresearch.biz/report/biochemistry-analyzers-market/request-sample

Biochemistry Analyzers Market Segmentation Overview:

Global biochemistry analyzers market segmentation, by type:

Semi-AutomaticFully AutomaticGlobal biochemistry analyzers market segmentation, by modality:

Bench TopFloor StandingGlobal biochemistry analyzers market segmentation, by end user:

HospitalsDiagnostics CentersAcademic Research InstitutesContract Research OrganizationsPharmaceutical and Biotechnology Companies

The research provides answers to the following key questions:

1) Who are the key Top Competitors in the Global Biochemistry Analyzers Market?

Following are the list of key players: Abbott Laboratories, Danaher Corporation, Hoffman-La Roche Ltd, Meril, Siemens AG, Hologic Inc, Thermo Fisher Scientific Inc, Randox Laboratories Ltd, Beckman Coulter Inc, Horiba Medical

2) What is the expected market size and growth rate of the Biochemistry Analyzers market for the period 2020-2029?

** The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with you.

3) Which Are The Main Key Regions Cover in Reports?

Geographically, this report is segmented into several key Regions, consumption, revenue (million USD), and market share and growth rate of Biochemistry Analyzers in these regions, from 2020 to 2029 (forecast), covering North America, Europe, Asia-Pacific, etc

4) Can I include additional segmentation/market segmentation?

Yes. Additional granularity/market segmentation may be included depending on data availability and the difficulty of the survey. However, you should investigate and share detailed requirements before final confirmation to the customer.

Global Biochemistry Analyzers Market Research Report comprises holistic business information and changing trends in the current market that enables users to spot the pin-point analysis of the market along with growth, revenue and profit during the forecast period 2020-2029. It provides an in-depth study of Biochemistry Analyzers Market by using SWOT analysis. This gives a complete analysis of drivers, restraints, and opportunities of the market. Additionally, the report provides a detailed study of top players within the market by highlighting their product description, business overview, and business strategy. It also endows with a quantity of production, required raw material, future demand, and the money health of the organization.

Inquire/Speak To Expert for Further Detailed Information About Biochemistry Analyzers Report:https://marketresearch.biz/report/biochemistry-analyzers-market/#inquiry

Biochemistry Analyzers market research report also involves the manufacturing process along with shipment, price, interview records, gross profit, potential, revenue, business distribution, etc. This enables users to get a complete scenario of competitive analysis of the market.

Also, Biochemistry Analyzers survey report offers Porters Five Forces analysis and PESTLE analysis for more detailed contrast studies. Each section of the report has something valuable that helps companies for improving their sales and marketing strategy, gross margin, and profit margins. Using the report as a tool for gaining insightful Biochemistry Analyzers market analysis, players can identify the much-required changes in their operation and improve their approach to doing business.

In this study, the years considered to estimate the market size of the Biochemistry Analyzers are as follows:

Base Year: 2019 | Estimated Year:2020 | Forecast Year: 2020 to 2029

Table of Content:

Market Outline:The report lists the merchandise overview, applications, product highlights including price, revenue, sales, rate of growth, and market share study.

Competition by Top Players:Worldwide market players and their Biochemistry Analyzers competition by the newest trends, market share, expansion, sales, and acquisitions are stated.

Business Profiles and Sales Analysis:This section stated the sales analysis of top Biochemistry Analyzers Market, manufacturing base, top regions, specifications, and merchandise details are stated.

Market Position and Regional Level View:during this part, the report states the CAGR value, market size estimation by regions and top countries present in North America, Europe, Asia-Pacific, Middle East, and Africa and South America.

Application or user Segment Analysis:This part explains the wide selection of applications that contribute to Biochemistry Analyzers marketing research

Forecast Trend Analysis:Here, the report states forecast Biochemistry Analyzers Industry view and revenue estimates for various segments like product, types, and applications for the forecast period from 2020-2029.

Research Outcomes and Inference:This part of the report mentions the analyst opinions and findings of Biochemistry Analyzers Market.

Appendix Section:Here, weve stated the disclaimer, data sources, research methodology, data triangulation, market breakdown.

Get the entire Access Of Report With TOC @ :https://marketresearch.biz/report/biochemistry-analyzers-market/#toc

Definitively, Biochemistry Analyzers report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.

About Us

MarketResearch.biz is a global market research and consulting service provider specialized in offering a wide range of business solutions to their clients including market research reports, primary and secondary research, demand forecasting services, focus group analysis and other services. We understand that how data is important in todays competitive environment and thus, we have collaborated with industrys leading research providers who work continuously to meet the ever-growing demand for market research reports throughout the year.

Contact Us:

Mr. Benni Johnson

Prudour Pvt. Ltd.

420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Tel:+ 1-347-826-1876

Website:https://marketresearch.biz/

Email ID:inquiry@marketresearch.biz

Thanks a million for reading! You can also request custom information like chapter-wise or specific region-wise study as per your interest.

See the rest here:
The Business Strategies Accepted By Leading Players In The Biochemistry Analyzers Market | (List: Abbott Laboratories,Danaher Corporation and more) -...

Astrobiologist explains why there may be invisible aliens among us. – Tech Ballad

Life is pretty easy to learn. He moves, he grows, he eats, he secrete, he multiplies. Simply. In biology, researchers often use the abbreviation MRSGREN to describe it. It refers to movement, breathing, sensitivity, growth, reproduction, excretion and nutrition.

But Helen Sharman, the first British astronaut and chemist at Imperial College London, recently said that alien life forms that cannot be found can live among us. How could this be possible?

Although life can be easily recognized, it is actually difficult to define, and scientists and philosophers have argued for centuries, if not millennia. For example, a 3D printer can reproduce itself, but we would not call it alive. On the other hand, the mule is famously sterile, but we would never say that he does not live.

As no one can agree, there are over 100 definitions of what life is. An alternative (but imperfect) approach describes life as a self-sustaining chemical system capable of Darwin evolution, which works in many of the cases that we want to describe.

(Read: aliens exist, but we are not open enough to see them)

Lack of definition is a huge problem when it comes to finding life in space. Failure to define life other than we will know it when we see it means that we really confine ourselves to geocentric, perhaps even anthropocentric ideas about how life looks. When we think of aliens, we often portray humanoid creatures. But the intelligent life we seek does not have to be humanoid.

Sharman says that she believes that aliens exist, and there are no two ways. She also wonders: Will they look like you and me, made up of carbon and nitrogen? Probably no. Perhaps they are here now, and we simply cannot see them.

Such a life will exist in the shadow biosphere. By this I do not mean the realm of ghosts, but undetected creatures, possibly with a different biochemistry. This means that we cannot study or even notice them, because they are beyond our comprehension. Assuming that it exists, such a shadow biosphere is likely to be microscopic.

So why didnt we find it? We have limited opportunities to study the microscopic world, since only a small percentage of microbes can be cultured in the laboratory. This may mean that there really can be many life forms that we have not yet noticed. Now we have the opportunity to sequence the DNA of uncultured strains of microbes, but this can only be detected by the life that we know which contains DNA.

However, if we find such a biosphere, it is not clear whether we should call it a stranger. It depends on whether we mean extraterrestrial origin or simply unfamiliar.

A popular alternative biochemistry proposal is based on silicon, not carbon. This makes sense even from a geocentric point of view. About 90 percent of the Earth is made up of silicon, iron, magnesium and oxygen, which means there are many opportunities for creating potential life.

Artists impression of silicone life form. Zita

Silicon is like carbon, it has 4 electrons to create bonds with other atoms. But silicon is heavier, with 14 protons (protons make up the atomic nucleus with neutrons) compared with six in the carbon nucleus. Although carbon can create strong double and triple bonds to form long chains, useful for many functions, such as building cell walls, silicon is much more complex. He is struggling to create strong bonds, so molecules with long chains are much less stable.

Moreover, conventional silicon compounds, such as silicon dioxide (or silicon dioxide), are usually solid at terrestrial temperatures and insoluble in water. Compare this, for example, with highly soluble carbon dioxide, and we will see that carbon is more flexible and provides much more molecular possibilities.

Life on Earth is fundamentally different from the basic composition of the Earth. Another argument against the silicon-based shadow biosphere is that there is too much silicon in the rocks. In fact, the chemical composition of life on Earth has an approximate correlation with the chemical composition of the Sun, with 98 percent of the atoms in biology being made up of hydrogen, oxygen, and carbon. So, if there were viable life forms of silicon, they could have developed elsewhere.

However, there are arguments in favor of silicon-based life on Earth. Nature is adaptable. A few years ago, scientists at the California Institute of Technology managed to bring out a bacterial protein that created bonds with silicon essentially driving silicon. Thus, although silicon is inflexible compared to carbon, it may be able to find ways to assemble into living organisms, potentially including carbon.

And when it comes to other places in space, such as the moon of Saturns Titan or planets orbiting other stars, we certainly cannot rule out the possibility of life based on silicon.

To find it, we must somehow think outside the framework of terrestrial biology and find ways to recognize life forms that are fundamentally different from carbon-based forms. There are many experiments to test these alternative biochemical methods, for example, from Caltech

Regardless of the belief of many that life exists elsewhere in the universe, we have no evidence of this. Therefore, it is important to consider all life as precious, regardless of its size, quantity or location. Earth supports the only known life in the universe. Therefore, no matter what form life can take elsewhere in the solar system or the universe, we must be sure that we will protect it from harmful pollution whether it be earthly life or alien life forms.

So can aliens be among us? I do not believe that we were visited by a living form with the technology to travel through vast outer spaces. But we have evidence that carbon-based life-forming molecules arrived on Earth on meteorites, so the data certainly does not preclude the same possibility for more unfamiliar life forms.

This article is reprinted from Conversation by Samantha Rolfe, lecturer in astrobiology and chief technical specialist at the Bayfordbury Observatory, University of Hertfordshire, licensed under Creative Commons. Read the original article.

See the original post:
Astrobiologist explains why there may be invisible aliens among us. - Tech Ballad

What’s on Your Shelf? Recommended Reading in the New Year – Healio

Over the past few years in this column, I have occasionally shouted out a book I have read and I have occasionally been rewarded by more than a few of my readers then sharing with me their thoughts and experiences of these same works. As the first editorial of 2020, I thought it might be fun to go to my bookshelf and share a number of the titles I have read over the past year.

I always read both nonfiction and fiction at the same time, but I am only going to give you my nonfiction picks. To get my fiction reading list, you will have to buy me a glass of wine so I can wave my hands and tell you why I picked certain books. A second caveat is that I must be truthful and tell you that I often buy the Kindle version of a nonfiction book first, and if I really like it, then I buy the real deal because I like to write and scribble in my books. I am not sure what that says about me but thats the way it is and virtually all have come into my passion this way.

Leonard H.Calabrese

There is no total unifying theme of the nine books I am recommending to you but, after looking at this stack, I think I found a few threads. My intention in this column is to give you enough information that will tempt you to pick one or more up on the basis of our shared interests. The first theme surrounds my work, namely the field of immunology in all its glory. There are three books that deal with my field and thus one may wonder what there could be in books written for the lay public that would make heart a card-carrying immunology guys heart sing to read? The answer is easy. Its all about the humanity.

In An Elegant Defense, Matt Richtel recounts stories of real patients with HIV, rheumatoid arthritis, and cancer intersecting with therapeutic advances in the field, and the enormous impact these changes have had on them. In The Breakthrough, Charles Graeber details the backstory of the people behind the development of checkpoint inhibitors, including many colorful interviews with Nobel Laureate James P. Allison, PhD even for me, actively working in the field, this was a terrific read.

Finally, the real sleeper in the immunology cassette, is The Beautiful Cure by Daniel M. Davis, which despite not garnering the press it deserves, in my opinion is a brilliant treatise on the evolution of the field of immunology over the past century. The book is written in scholarly fashion, but laced with terrific backstories in the style of The Gene by Siddhartha Mukherjee. Read it!

Switching gears, The Compassionate Connection by David Rakel and Suggestible You by Eric Vance are all about placebo science and the role of interpersonal relationships in building wellness and healing. Both of these are great reads and I am planning on a cover story/roundtable in the spring on placebo science in rheumatology. See how this works now?

The Longevity Diet by Valter Longo, PhD, a leading researcher in aging/longevity research is a terrific read on something we all share an interest in namely how to eat and living a long life. I find choosing books in the wellness field often problematic given the myriad of bugnutty offerings out there, but I assure you, Dr. Longo is a scientist in the truest sense of the word. I recently hosted him at my 2019 Cleveland Clinic Biologic Therapies VIII Summit, a presentation you will be able to watch when it posts on our website in the near future.

In my previous editorials in February 2019 and April 2019, I have already discussed the profound impact of The Empathy Effect by Helen Reiss, MD, and Deep Medicine by Eric Topol, MD, so I will not expound on them again if you havent picked up by now, please do. Perhaps counterintuitively, I believe these books on empathy and artificial intelligence are intimately related. As I have written in the past, one of the most exciting and challenging areas of investigation lying ahead is how to bring empathy to the growing onslaught of AI, machine learning and technology. We must figure this out.

Finally, why did Leonardo Da Vinci, by the noted biographer Walter Isaacson, make it to my bedside reading table? There are many reasons, perhaps prominent among them that 2019 was the 500th anniversary of the death of the most curious man with the greatest mind the world has ever known. Probably more important is a passion to learn about him instilled by a friend and a physician, humanist and Da Vinci scholar, Sal Mangione, MD, from Thomas Jefferson University.

I have heard Dr. Mangione speak on Da Vinci many times, and he has also graced our Medical Grand Rounds podium frequently discussing art, observation and humanism. His passion for the life, work and genius of Leonardo Da Vinci is quite infectious, and the book is a great start to understanding the master Thank you Sal, I am hooked.

These are my nonfiction picks from the last year tell me about yours through Twitter at @LCalabreseDO or email me at calabrl@ccf.org.

Disclosures: Calabrese reports consulting relationships with AbbVie, Centecor Biopharmaceutical, Crescendo Bioscience, GlaxoSmithKline, Horizon Pharma, Janssen Pharmaceuticals, Pfizer, Regeneron Pharmaceuticals and UCB.

Over the past few years in this column, I have occasionally shouted out a book I have read and I have occasionally been rewarded by more than a few of my readers then sharing with me their thoughts and experiences of these same works. As the first editorial of 2020, I thought it might be fun to go to my bookshelf and share a number of the titles I have read over the past year.

I always read both nonfiction and fiction at the same time, but I am only going to give you my nonfiction picks. To get my fiction reading list, you will have to buy me a glass of wine so I can wave my hands and tell you why I picked certain books. A second caveat is that I must be truthful and tell you that I often buy the Kindle version of a nonfiction book first, and if I really like it, then I buy the real deal because I like to write and scribble in my books. I am not sure what that says about me but thats the way it is and virtually all have come into my passion this way.

Leonard H.Calabrese

There is no total unifying theme of the nine books I am recommending to you but, after looking at this stack, I think I found a few threads. My intention in this column is to give you enough information that will tempt you to pick one or more up on the basis of our shared interests. The first theme surrounds my work, namely the field of immunology in all its glory. There are three books that deal with my field and thus one may wonder what there could be in books written for the lay public that would make heart a card-carrying immunology guys heart sing to read? The answer is easy. Its all about the humanity.

In An Elegant Defense, Matt Richtel recounts stories of real patients with HIV, rheumatoid arthritis, and cancer intersecting with therapeutic advances in the field, and the enormous impact these changes have had on them. In The Breakthrough, Charles Graeber details the backstory of the people behind the development of checkpoint inhibitors, including many colorful interviews with Nobel Laureate James P. Allison, PhD even for me, actively working in the field, this was a terrific read.

Finally, the real sleeper in the immunology cassette, is The Beautiful Cure by Daniel M. Davis, which despite not garnering the press it deserves, in my opinion is a brilliant treatise on the evolution of the field of immunology over the past century. The book is written in scholarly fashion, but laced with terrific backstories in the style of The Gene by Siddhartha Mukherjee. Read it!

Switching gears, The Compassionate Connection by David Rakel and Suggestible You by Eric Vance are all about placebo science and the role of interpersonal relationships in building wellness and healing. Both of these are great reads and I am planning on a cover story/roundtable in the spring on placebo science in rheumatology. See how this works now?

The Longevity Diet by Valter Longo, PhD, a leading researcher in aging/longevity research is a terrific read on something we all share an interest in namely how to eat and living a long life. I find choosing books in the wellness field often problematic given the myriad of bugnutty offerings out there, but I assure you, Dr. Longo is a scientist in the truest sense of the word. I recently hosted him at my 2019 Cleveland Clinic Biologic Therapies VIII Summit, a presentation you will be able to watch when it posts on our website in the near future.

PAGE BREAK

In my previous editorials in February 2019 and April 2019, I have already discussed the profound impact of The Empathy Effect by Helen Reiss, MD, and Deep Medicine by Eric Topol, MD, so I will not expound on them again if you havent picked up by now, please do. Perhaps counterintuitively, I believe these books on empathy and artificial intelligence are intimately related. As I have written in the past, one of the most exciting and challenging areas of investigation lying ahead is how to bring empathy to the growing onslaught of AI, machine learning and technology. We must figure this out.

Finally, why did Leonardo Da Vinci, by the noted biographer Walter Isaacson, make it to my bedside reading table? There are many reasons, perhaps prominent among them that 2019 was the 500th anniversary of the death of the most curious man with the greatest mind the world has ever known. Probably more important is a passion to learn about him instilled by a friend and a physician, humanist and Da Vinci scholar, Sal Mangione, MD, from Thomas Jefferson University.

I have heard Dr. Mangione speak on Da Vinci many times, and he has also graced our Medical Grand Rounds podium frequently discussing art, observation and humanism. His passion for the life, work and genius of Leonardo Da Vinci is quite infectious, and the book is a great start to understanding the master Thank you Sal, I am hooked.

These are my nonfiction picks from the last year tell me about yours through Twitter at @LCalabreseDO or email me at calabrl@ccf.org.

Disclosures: Calabrese reports consulting relationships with AbbVie, Centecor Biopharmaceutical, Crescendo Bioscience, GlaxoSmithKline, Horizon Pharma, Janssen Pharmaceuticals, Pfizer, Regeneron Pharmaceuticals and UCB.

Read more:
What's on Your Shelf? Recommended Reading in the New Year - Healio

Hope for patients with a rare genetic condition linked to severe infections – Newswise

MEDIA CONTACT

Available for logged-in reporters only

Journal of Allergy and Clinical Immunology, January 2020

Newswise A team of researchers at CHU Sainte-Justine and Universit de Montral has shed light on the mechanisms that underlie a rare genetic condition by creating the first cellular model of the disease. The study's findings were published today in the Journal of Allergy and Clinical Immunology.

Chronic granulomatous disease (CGD) is a rare hereditary condition that affects one in every 217,000 people worldwide and typically strikes patients at an early age.

It is a primary innate immune defect that typically leads to severe, recurrent infections caused by bacteria and fungi, as well as potentially disabling lung inflammation or inflammatory colitis similar to Crohns disease, said senior author Dr.FabienTouzot, a clinical assistant professor in pediatric medicine at UdeM and researcher in pediatric immunology and hematology at CHU Sainte-Justine.

Currently, patients are forced to take antibiotics and anti-inflammatory drugs for the rest of their lives.

Gene editing shows the way forward

To better understand the mechanisms that trigger inflammation in patients with CGD, Touzot and his research team created the very first cellular model of the disease in their labs at CHU Sainte-Justine. They then used a technique known as gene editing to recreate and introduce into their model a genetic mutation that causes the disease. This allowed them to model the inflammatory response observed in patients and to study its mechanisms.

CGD is a hereditary illness caused by mutations in the NADPH oxidase enzyme. These mutations prevent white blood cells from working properly and, as a result, the patients body can no longer defend itself against certain kinds of bacteria and fungi, said researcher Aissa Benyoucef, the studys first author.

More than 90% of affected patients have inflammation that appears to be unrelated to infectious agents," he added. "Treating this inflammation is difficult, since it can put patients at increased risk of infection, which can sometimes be fatal. A better understanding of the mechanisms underlying the disease could help us develop new and more effective treatment strategies.

The research team showed that restoring NADPH oxydase function in defective cells would put the immune process back on track, thereby proving that this genetic mutation plays a direct role in causing inflammation.

CHU Sainte-Justine is one of Quebecs leading centres of expertise in rare genetic diseases," said Touzot. "Were proud to serve patients by expanding the knowledge base in this area and by contributing to the development of precision medicine."

The new cellular model will be useful for the development of targeted treatments that are less toxic and more effective in treating inflammation, significantly improving patient quality of life, according to the researchers.

About this study

CRISPR gene-engineered CYBBko THP-1 cell lines highlight the crucial role of NADPH-induced reactive oxygen species for regulating inflammasome activation was published in the January 2020 edition of the Journal of Allergy and Clinical Immunology. The first author is Aissa Benyoucef, PhD, a lab employee under the supervision of Dr. Fabien Touzot. The senior author is Dr. Touzot, MD, PhD, a clinical assistant professor at Universit de Montreals Department of Pediatrics and clinician-researcher in pediatric immunology and hematology at CHU Sainte-Justine. The study was paid by a CHU Sainte-Justine Research Centre start-up fund and by Fondation Charles-Bruneau.

About the CHU Sainte-Justine Research Centre

The CHU Saint-Justine Research Centre is a flagship institution in mother-child research affiliated with Universit de Montral. Focused on the discovery of innovative means of prevention, less intrusive and faster treatments and promising avenues of personalized medicine, it brings together more than 210 researchers, including more than 90 clinical researchers, as well as 450 graduate students and postdoctoral fellows. The centre is an integral part of the Centre hospitalier universitaire Sainte-Justine, the largest mother-child centre in Canada. Details at https://research.chusj.org/en/Home

Read more from the original source:
Hope for patients with a rare genetic condition linked to severe infections - Newswise

Cancer immune cell: what have scientists discovered? – The Week UK

The discovery of a killer cell in the human immune system could lead to a one-size-fits-all cancer treatment, according to a newly published study.

The team of Cardiff University researchers who made the find say the T-cell has already been used in lab tests to attack and destroyprostate, breast, lung and other cancer cells.

Although no tests have been conducted yet on human patients, scientists say the findings - outlined in a newly publishedpaperin the journal Nature Immunology -haveenormous potential, the BBC reports.

One of the most groundbreaking advances in the fight against cancer in recent years is a treatment known as CAR-T immunotherapy. This therapy involves harvesting a patients immune T-cells and reprogramming them to target specific proteins found on the patients cancer cells, while leaving healthy cells undamaged, explains science news siteNew Atlas.

However, a major limitation facing researchers of CAR-T therapies has been the lack of a universal T-cell receptor (TCR) that can target different kinds of cancers in all patients.

But the T-cell discovered by the Welsh university team appears to be equipped with a new type of TCR that does exactly that.

This T-cell recognises a molecule present on the surface of a wide range of cancer cells, and normal cells, and is able to distinguish between healthy and cancerous cells - killing only the latter, The Independentreports.

In lab tests on mice and human cells, the T-cells equipped with the new TCR has been found to kill lung, skin, blood, colon, breast, bone, prostate, ovarian, kidney and cervical cancer cells.

If these sorts of effects can be replicated in humans,says ScienceAlert, we could be looking at a bright new future for T-cell treatments.

According to Wales Online, experiments are under way to determine the precise molecular mechanism by which the new TCR distinguishes between healthy cells and cancer, and researchers hope to begin human patients towards the end of this year following further safety testing.

Cardiff University professor Awen Gallimore, a cancer immunology lead for the Wales Cancer Research Centre, said: If this transformative new finding holds up, it will lay the foundation for a universal T-cell medicine, mitigating against the tremendous costs associated with the identification, generation and manufacture of personalised T-cells.

This is truly exciting and potentially a great step forward for the accessibility of cancer immunotherapy.

Alasdair Rankin of blood cancer charity Bloodwise added: This research represents a new way of targeting cancer cells that is really quite exciting, although much more research is needed to understand precisely how it works.

Go here to read the rest:
Cancer immune cell: what have scientists discovered? - The Week UK

Hairy cells in the nose called brush cells may be involved in causing allergies – Science News

Some hairy cells in the nose may triggersneezing and allergies to dust mites, mold and other substances, new work withmice suggests.

When exposed to allergens, these brushcells make chemicals that lead to inflammation, researchers report January17 in Science Immunology. Only immunecells previously were thought to make such inflammatory chemicals fattycompounds known as lipids. The findings may provide new clues about how peopledevelop allergies.

Brush cells are shaped like teardropstopped by tufts of hairlike projections. In people, mice and other animals, thesecells are also found in the linings of the trachea and the intestines, wherethey are known as tuftcells (SN: 4/13/18). However, brushcells are far more common in the nose than in other tissues, and may help thebody identify when pathogens or noxious chemicals have been inhaled, says LoraBankova, an allergist and immunologist at Brigham and Womens Hospital inBoston.

Bankova and her colleagues discoveredthat, when exposed to certain molds or dust mite proteins, brush cells inmices noses churn out inflammation-producing lipids, called cysteinylleukotrienes. The cells also made the lipids when encountering ATP, a chemical usedby cells for energy that also signals when nearby cells are damaged, as in aninfection. Mice exposed to allergens or ATP developed swelling of their nasaltissues. But mice that lacked brush cells suffered much less inflammation.

Such inflammation may lead to allergiesin some cases. The researchers havent yet confirmed that brush cells in humannoses respond to allergens in the same way as these cells do in mice.

See original here:
Hairy cells in the nose called brush cells may be involved in causing allergies - Science News